Methods For Treating Cancer
AssigneeRadius Pharmaceuticals, Inc.
InventorGary Hattersley
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods of treating one or more tumors by administering to the subject a therapeutically effective amount of a combination of RAD1901 or solvates (e.g., hydrate) or salts thereof and one or more second therapeutic agent(s) (e.g., everolimus). The cancer is an estrogen-dependent cancer, such as breast cancer, ovarian cancer, colon cancer, endometrial cancer, or prostate cancer.
Claims25
1-18. (canceled)
A method of treating breast cancer in a subject having an estrogen receptor alpha-positive cancer that is drug-resistant and/or has a mutant estrogen receptor alpha comprising administering to said subject a therapeutically effective amount of a combination of an m-TOR inhibitor and RAD1901 having the structure:
- or a salt or solvate thereof.
(canceled)
30-31. (canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.